These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 15919240

  • 1. Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency.
    Kreuz W, Meili E, Peter-Salonen K, Haertel S, Devay J, Krzensk U, Egbring R.
    Transfus Apher Sci; 2005 Jun; 32(3):247-53. PubMed ID: 15919240
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Results of an international, multicentre pharmacokinetic trial in congenital fibrinogen deficiency.
    Peyvandi F.
    Thromb Res; 2009 Dec; 124 Suppl 2():S9-11. PubMed ID: 20109654
    [Abstract] [Full Text] [Related]

  • 4. Fibrinogen concentrate for acquired hypofibrinogenaemic states.
    Weinkove R, Rangarajan S.
    Transfus Med; 2008 Jun; 18(3):151-7. PubMed ID: 18598277
    [Abstract] [Full Text] [Related]

  • 5. Retrochorionic hematoma in congenital afibrinogenemia: resolution with fibrinogen concentrate infusions.
    Aygören-Pürsün E, Martinez Saguer I, Rusicke E, Louwen F, Geka F, Ivaskevicius V, Oldenburg J, Klingebiel T, Kreuz W.
    Am J Hematol; 2007 Apr; 82(4):317-20. PubMed ID: 17034026
    [Abstract] [Full Text] [Related]

  • 6. Fibrinogen concentrate--a potential universal hemostatic agent.
    Fenger-Eriksen C, Ingerslev J, Sørensen B.
    Expert Opin Biol Ther; 2009 Oct; 9(10):1325-33. PubMed ID: 19645632
    [Abstract] [Full Text] [Related]

  • 7. Epidemiology and treatment of congenital fibrinogen deficiency.
    Peyvandi F.
    Thromb Res; 2012 Dec; 130 Suppl 2():S7-11. PubMed ID: 23439004
    [Abstract] [Full Text] [Related]

  • 8. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M, Toh CH, Thachil J, Watson HG.
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register.
    Weiss G, Lison S, Glaser M, Herberger S, Johanning K, Strasser T, Huber T, Spannagl M, Heindl B.
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):727-34. PubMed ID: 22024795
    [Abstract] [Full Text] [Related]

  • 13. Spontaneous intracranial bleeding in two patients with congenital afibrinogenaemia and the role of replacement therapy.
    Parameswaran R, Dickinson JP, de Lord S, Keeling DM, Colvin BT.
    Haemophilia; 2000 Nov; 6(6):705-8. PubMed ID: 11122402
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of fibrinogen concentrate for on-demand treatment of bleeding and surgical prophylaxis in paediatric patients with congenital fibrinogen deficiency.
    Djambas Khayat C, Lohade S, D'Souza F, Shamanur LG, Zekavat OR, Kruzhkova I, Schwartz B, Solomon C, Knaub S, Peyvandi F.
    Haemophilia; 2021 Mar; 27(2):283-292. PubMed ID: 33326665
    [Abstract] [Full Text] [Related]

  • 15. [Fibrinogen substitution. Use in the treatment of bleeding due to lack of fibrinogen].
    Ingerslev J, Sørensen B.
    Ugeskr Laeger; 2005 Jun 20; 167(25-31):2759-61. PubMed ID: 16014260
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial.
    Lissitchkov T, Madan B, Djambas Khayat C, Zozulya N, Ross C, Karimi M, Kavakli K, De Angulo GR, Almomen A, Schwartz BA, Solomon C, Knaub S, Peyvandi F.
    Transfusion; 2018 Feb 20; 58(2):413-422. PubMed ID: 29194665
    [Abstract] [Full Text] [Related]

  • 17. Congenital afibrinogenaemia.
    Mehta S, Mehta SR, Malhotra H, Sharma UB, Varma AR.
    J Assoc Physicians India; 1989 Oct 20; 37(10):668-9. PubMed ID: 2490152
    [Abstract] [Full Text] [Related]

  • 18. [Not Available].
    Bor MV.
    Ugeskr Laeger; 2024 Jan 01; 186(1):. PubMed ID: 38235772
    [Abstract] [Full Text] [Related]

  • 19. Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders?
    Bevan DH.
    Thromb Res; 2009 Dec 01; 124 Suppl 2():S12-6. PubMed ID: 20109651
    [Abstract] [Full Text] [Related]

  • 20. Highly purified VWF/FVIII concentrates in the treatment and prophylaxis of von Willebrand disease: the PRO. WILL Study.
    Federici AB.
    Haemophilia; 2007 Dec 01; 13 Suppl 5():15-24. PubMed ID: 18078393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.